Siramesine Attenuates Early Brain Injury Through the TMEM97/NPC1 Pathway After Experimental Subarachnoid Hemorrhage in Rats

The occurrence of oxidative stress and apoptosis is closely associated with early brain injury (EBI) following subarachnoid hemorrhage (SAH). Currently, there is a lack of effective therapeutic targets or specific pharmacological agents to counteract oxidative stress and cell death after SAH. Our study demonstrates that the TMEM97/NPC1 signaling pathway plays a significant role in EBI in rats with SAH. TMEM97 protein expression in rat brain tissue progressively decreased after SAH, reaching its lowest level at 24 h. Immunofluorescence double-staining further confirmed a notable reduction in TMEM97-positive neurons at 24 h post-SAH. Treatment with Siramesine, a reported TMEM97 activator, was observed to ameliorate both short-term and long-term neurological deficits in SAH rats. The administration was also associated with a reduction in oxidative stress and suppression of neuronal apoptosis. At the molecular level, Siramesine treatment correlated with upregulation of TMEM97, NPC1, DJ-1, and the anti-apoptotic protein Bcl-2, alongside downregulation of the mitochondrial fission protein Drp1, the oxidative stress-related protein Romo-1, and the pro-apoptotic protein Bax. Notably, the protective effects of Siramesine were significantly, though not completely, attenuated by co-administration of the TMEM97 inhibitor SM-21 or by NPC1 siRNA. The partial nature of this reversal, particularly with the TMEM97 antagonist SM-21, indicates that while TMEM97 activation constitutes a significant component of Siramesine's mechanism, it is unlikely to be the sole contributor to its full neuroprotective effect. Collectively, these results suggest that the TMEM97/NPC1 pathway is involved in the neuroprotective actions of Siramesine, while also implying the potential engagement of additional, complementary mechanisms. This study provides a foundation for future preclinical investigations aimed at further elucidating this complex mechanism.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2025-11-23
DOI
https://doi.org/10.1096/fj.202401530rr
Primary Topic
Intracranial Aneurysms: Treatment and Complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Siramesine Attenuates Early Brain Injury Through the TMEM97/NPC1 Pathway After Experimental Subarachnoid Hemorrhage in Rats

Huaizhang Shi, Jianqiao Li, Bohan Zhang, Qi Sun et al.
The FASEB Journal
Intracranial Aneurysms: Treatment and Complications
article

Siramesine Attenuates Early Brain Injury Through the TMEM97/NPC1 Pathway After Experimental Subarachnoid Hemorrhage in Rats

Huaizhang Shi, Jianqiao Li, Bohan Zhang, Qi Sun, Lining Chen, Harshal Sawant, Qi Zhao, Tongyu Zhang, Bowen Sun, John H. Zhang, Xiao Dan Wang, Jinshuo Yang, Pei Wu, Shuai Lan
article en

Abstract

The occurrence of oxidative stress and apoptosis is closely associated with early brain injury (EBI) following subarachnoid hemorrhage (SAH). Currently, there is a lack of effective therapeutic targets or specific pharmacological agents to counteract oxidative stress and cell death after SAH. Our study demonstrates that the TMEM97/NPC1 signaling pathway plays a significant role in EBI in rats with SAH. TMEM97 protein expression in rat brain tissue progressively decreased after SAH, reaching its lowest level at 24 h. Immunofluorescence double-staining further confirmed a notable reduction in TMEM97-positive neurons at 24 h post-SAH. Treatment with Siramesine, a reported TMEM97 activator, was observed to ameliorate both short-term and long-term neurological deficits in SAH rats. The administration was also associated with a reduction in oxidative stress and suppression of neuronal apoptosis. At the molecular level, Siramesine treatment correlated with upregulation of TMEM97, NPC1, DJ-1, and the anti-apoptotic protein Bcl-2, alongside downregulation of the mitochondrial fission protein Drp1, the oxidative stress-related protein Romo-1, and the pro-apoptotic protein Bax. Notably, the protective effects of Siramesine were significantly, though not completely, attenuated by co-administration of the TMEM97 inhibitor SM-21 or by NPC1 siRNA. The partial nature of this reversal, particularly with the TMEM97 antagonist SM-21, indicates that while TMEM97 activation constitutes a significant component of Siramesine's mechanism, it is unlikely to be the sole contributor to its full neuroprotective effect. Collectively, these results suggest that the TMEM97/NPC1 pathway is involved in the neuroprotective actions of Siramesine, while also implying the potential engagement of additional, complementary mechanisms. This study provides a foundation for future preclinical investigations aimed at further elucidating this complex mechanism.

The FASEB JournalVol. 39(22)
Harbin Medical University (CN), Capital Medical University (CN), Loma Linda University (US), Mudanjiang Medical University (CN), First Affiliated Hospital of Harbin Medical University (CN), Marshall University (US)
Openalex Percentile: Top 50%
Intracranial Aneurysms: Treatment and Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.